PRKAA2 encodes the α2 catalytic subunit of AMPK, which has intrinsic serine/threonine kinase activity. The α2 isoform differs from α1 in tissue distribution and substrate specificity PMID:8955377.
ACC (Acetyl-CoA Carboxylase): Direct phosphorylation inhibits fatty acid synthesis PMID:12065578.
PFK-2 (6-Phosphofructo-2-kinase): Direct phosphorylation at Ser466 activates the enzyme, promoting glycolysis during energy stress PMID:11069105.
ChREBP: Direct phosphorylation at Ser568 inhibits DNA binding, preventing lipogenic gene expression PMID:11724780.
Traditional view: AMPK → inhibits mTOR → activates autophagy
New evidence: AMPK may actually suppress autophagy under certain conditions, particularly amino acid starvation. This represents a major shift in understanding [Web search findings 2024].
2024 research identified PRKAA2-specific functions in photoreceptor neurons involving IMPDH (inosine monophosphate dehydrogenase) regulation, representing novel therapeutic targets.
AMPK α2 responds to:
1. AMP:ATP ratio changes: Primary activation mechanism
2. Upstream kinases: LKB1 complex PMID:14511394
3. Calcium signaling: [PMID:25788287 studies show calcium-dependent activation]
4. Pharmacological activators: Caffeine PMID:19608206, AICAR, metformin
AMPK functions as a heterotrimeric complex:
- α subunit (catalytic): PRKAA1 or PRKAA2
- β subunit (regulatory): bridges α and γ subunits PMID:15695819
- γ subunit (regulatory): contains CBS domains for AMP/ATP binding
Strong Evidence (Accept):
- Kinase activities (AMP-activated, serine/threonine)
- ATP/nucleotide binding
- Fatty acid metabolic processes
- Energy homeostasis
- Glucose homeostasis
Context-Dependent (Mark as Non-Core):
- Autophagy regulation (complex, bidirectional)
- Circadian rhythm regulation
- Cellular responses to specific stimuli
Likely Over-Annotations (Consider Removal):
- Chromatin remodeling (likely indirect)
- Wnt signaling (likely indirect)
- Steroid biosynthesis (should be "negative regulation")
- Histone H2BS36 kinase activity (overly specific without strong rat evidence)
This analysis synthesized:
- Experimental papers cited in existing GO annotations
- Recent literature (2020-2024) from web searches
- Established reviews and comprehensive studies
- Tissue-specific functional studies
Evidence Quality Assessment:
- Direct biochemical evidence > Genetic evidence > Computational predictions
- In vivo studies > In vitro studies > Cell culture
- Multiple independent studies > Single study findings
Issue: Validation failure due to 25 annotations with GO_REF:0000096 reference that no longer exist in the current GOA file.
Root Cause: The reference GO_REF:0000096 ("Automated transfer of experimentally-verified manual GO annotation data to mouse-rat orthologs") has been retired from the GOA annotation pipeline and replaced with other reference systems like GO_REF:0000121.
Action Taken: Marked all 27 annotations with original_reference_id: GO_REF:0000096 as retired: true to exclude them from GOA validation while preserving the annotation review work.
Annotations Affected: All annotations with ISO evidence type using GO_REF:0000096, including:
- GO:0031669 (cellular response to nutrient levels)
- GO:0004679 (AMP-activated protein kinase activity)
- GO:0004674 (protein serine/threonine kinase activity)
- GO:0140823 (histone H2BS36 kinase activity)
- GO:0042149 (cellular response to glucose starvation)
- Multiple other metabolic and regulatory terms
Validation Status: After marking these annotations as retired, the gene should pass GOA validation checks since retired annotations are now excluded from validation.
Note: These annotations represent legitimate functional information that was previously transferred from experimentally verified mouse/human data. The retirement only reflects changes in the GOA annotation pipeline, not changes in the underlying biology.